Dana Farber/Massachusetts General Hospital, Inc — Boston, Massachusetts

Dana Farber/Massachusetts General Hospital, Inc is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Dana Farber/Massachusetts General Hospital, Inc has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Solid Tumor.

Sponsors: PAQ Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber/Massachusetts General Hospital, Inc?

Dana Farber/Massachusetts General Hospital, Inc has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber/Massachusetts General Hospital, Inc conducted?

Dana Farber/Massachusetts General Hospital, Inc has 1 clinical trials on record, with 1 currently active. Their work covers Solid Tumor.

Is Dana Farber/Massachusetts General Hospital, Inc accredited by Crixeo Health?

Dana Farber/Massachusetts General Hospital, Inc has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana Farber/Massachusetts General Hospital, Inc?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.